Febrile episode unmasking neuropsychiatric systemic lupus erythematosus with lytic lesions caused by secondary autoimmune myelofibrosis: Case report.
Antibodies, Antinuclear
Autoimmune Diseases
/ complications
Autoimmunity
Cyclophosphamide
/ therapeutic use
Fatal Outcome
Female
Fever
/ etiology
Humans
Lupus Erythematosus, Systemic
/ complications
Lupus Vasculitis, Central Nervous System
/ complications
Magnetic Resonance Imaging
Middle Aged
Primary Myelofibrosis
/ complications
Treatment Outcome
Venous Thrombosis
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
23 Dec 2021
23 Dec 2021
Historique:
received:
03
11
2021
accepted:
25
11
2021
entrez:
23
12
2021
pubmed:
24
12
2021
medline:
23
2
2022
Statut:
ppublish
Résumé
Systemic lupus erythematosus (SLE) is characterized by numerous immunological abnormalities that lead to multiorgan involvement. Central and peripheral nervous system manifestations are present in 8% to 92% of the cases of SLE. Furthermore, there have been reported cases of secondary autoimmune myelofibrosis associated with SLE. We present the case of a 64-year-old female who was transferred from the Cardiology Department, where she was admitted for pericardial-pleural-peritoneal effusion after being discharged from another hospital following the resolution of a febrile episode. During hospitalization, she presented multiple oculomotor nerves palsies and weakness in the lower limbs. Serial cerebral magnetic resonance imaging (MRI) revealed extensive cerebral venous thrombosis. Nerve conduction studies showed sensory-motor axonal polyneuropathy. Thoracic MRI revealed a rare finding in patients with SLE - lytic lesions. Extensive clinical, imaging, blood, and urine tests were performed. The patient exhibited pancytopenia, elevated inflammatory markers, hyperhomocysteinemia, mild hypoproteinemia, and severe proteinuria. The Hematology consultation ascertained that the peripheral blood smear and the bone marrow aspiration showed no alterations suggestive for a primary hematological disease and the thoracic vertebral-medullary MRI changes had a very low probability of representing osteolytic lesions in the context of plasma cells dyscrasia, but could not exclude their being result of a secondary autoimmune myelofibrosis. Immunology blood tests highlighted the presence of antinuclear antibodies and lupus anticoagulants. In this context, the Rheumatology consultation established the diagnosis of SLE with multiple complications. The patient received treatment with cyclophosphamide. The ocular motricity problems and the paraparesis showed improvement. However, 1 week later, the patient developed weakness, dyspnea, and right lower quadrant abdominal pain. The abdominal-pelvic computed tomography scan indicated an acute right retroperitoneal hematoma with active bleeding for which she underwent arterial embolization of the spinal lumbar arteries with optimal result, but she died a few days later. We chose to present this case in order to highlight the importance of interdisciplinarity in diagnosing and managing patients with SLE and multiorgan ailments, especially when faced with rare constellations of complications such as extensive cerebral venous thrombosis and osseous lytic lesions caused by secondary autoimmune myelofibrosis.
Identifiants
pubmed: 34941099
doi: 10.1097/MD.0000000000028251
pii: 00005792-202112230-00075
pmc: PMC8702261
doi:
Substances chimiques
Antibodies, Antinuclear
0
Cyclophosphamide
8N3DW7272P
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e28251Subventions
Organisme : None
ID : no
Informations de copyright
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to declare.
Références
Carter EE, Barr SG, Clarke AE. The global burden of SLE: prevalence, health disparities and socioeconomic impact. Nat Rev Rheumatol 2016;12:605–20.
Bougea A, Anagnostou E, Konstantinos G, et al. A systematic review of peripheral and central nervous system involvement of rheumatoid arthritis, systemic lupus erythematosus, primary Sjögren's syndrome, and associated immunological profiles. Int J Chronic Dis 2015;2015:910352–1910352.
Philippe M, Emilie C, Zahir A, et al. Clinical spectrum and therapeutic management of auto-immune myelofibrosis: a nation-wide study of 30 cases. Haematologica 2020;106:871–4.
Riley DS, Barber MS, Kienle GS, et al. CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol 2017;89:218–35.
Fujieda Y. Diversity of neuropsychiatric manifestations in systemic lupus erythematosus. Immunol Med 2020;43:135–41.
Sibbitt WL Jr, Sibbitt RR, Brooks WM. Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 1999;42:2026–38.
Jeltsch-David H, Muller S. Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers. Nat Rev Neurol 2014;10:579–96.
Fayyaz A, Igoe A, Kurien BT, et al. Haematological manifestations of lupus. Lupus Sci Med 2015;2:e000078doi:10.1136/lupus-2014-000078.
doi: 10.1136/lupus-2014-000078